Medtronic and Novo Nordisk collaborate on digital diabetes solutions

September 23, 2019
Digital Transformation More...
by Nardev Ramanathan
Very important

The two diabetes care giants have teamed up to integrate dosing data from Novo Nordisk's smart insulin pens with Medtronic's Guardian Connect continuous glucose monitors (CGMs). This landmark move is critical for enabling greater interoperability in a relatively fragmented diabetes ecosystem. Both these industry heavyweights command a significant market share of the trillion-dollar diabetes industry, and this partnership enables millions of diabetes patients to seamlessly connect two critical parameters in diabetes management, insulin and blood glucose data. This partnership also unlocks the potential to gain deeper insights by combining larger datasets, helping support new business opportunities and better outcomes for patients.  

For the original news article, click here .

Further Reading

Ketogenic nutrition breath sensor developer closes $2.5 million seed round

News Commentary | November 30, 2018

A ketogenic diet forces the body into a state of mild ketosis, where the body preferentially burns fat as a result of low carbohydrate intake. The state of ketosis can be measured based on the level of acetone in a person's breath. Keyto, a company that develops an app with a connected device that ... Not part of subscription

Medtronic leverages AI for stroke care

News Commentary | August 02, 2019

Medtronic's diabetes products leverage the use of AI, most notably in its MiniMed 670G hybrid closed‑loop system, to maintain healthy blood glucose levels. It is now aiming to leverage AI for its stroke care business too. It entered into a global distribution agreement with, whose AI‑powered ... Not part of subscription

Aural Analytics receives $4.3 million in seed round for speech analytics for detecting brain health through speech analytics

News Commentary | September 11, 2019

The platform that Aural Analytics has developed is important because it offers the ability to detect changes in brain health that affect long‑term care, such as the onset of dementia and other cognitive impairment. Early detection of cognitive impairment can lead to better outcomes, as treatments ... Not part of subscription